Martine Monnat
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
Gonvers J, Troilliet N, Negro F, Monnat M, Malinverni R, Dutoit V, Dufour F, Chuard C, Chave J, Cerny A, Borovicka J, Bernasconi E, Genné D, Mullhaupt B, Cavassini M, Heim M, Oneta C. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010; 140:w13055.
19.07.2010Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study
19.07.2010Swiss Med Wkly 2010; 140:w13055
Gonvers Jean-Jacques, Troilliet Nicolas, Negro Francesco, Monnat Martine, Malinverni Raffaelle, Dutoit Valérie, Dufour François, Chuard Christian, Chave Jean-Philippe, Cerny Andreas, Borovicka Jan, Bernasconi Enos, Genné Daniel, Mullhaupt Beat, Cavassini Matthias, Heim Markus H, Oneta Carl
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Ciuffreda D, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers J, Pantaleo G, Oneta C, Malinverni R, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim M, Battegay M, Genné D, Mulhaupt B, Dutoit V. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European journal of immunology 2008; 38:2665-77.
01.10.2008Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
01.10.2008European journal of immunology 2008; 38:2665-77
Ciuffreda Donatella, Bernasconi Enos, Monnat Martine, Cerny Andreas, Chuard Christian, Borovicka Jan, Mentha Gilles, Pascual Manuel, Gonvers Jean-Jacques, Pantaleo Giuseppe, Oneta Carl, Malinverni Raffaele, Comte Denis, Cavassini Matthias, Giostra Emiliano, Buhler Leo, Perruchoud Monika, Heim Markus H, Battegay Manuel, Genné Daniel, Mulhaupt Beat, Dutoit Valérie
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs
Fried R, Frei M, Schönbucher P, Kölliker C, Broers B, Isler M, Herold M, Schmid P, Oppliger R, Seidenberg A, Monnat M, Huber M. Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. Digestion 2008; 78:123-30.
01.01.2008Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs
01.01.2008Digestion 2008; 78:123-30
Fried Ronald, Frei Markus, Schönbucher Peter, Kölliker Christoph, Broers Barbara, Isler Marc, Herold Markus, Schmid Patrick, Oppliger Robert, Seidenberg André, Monnat Martine, Huber Milo